Marker Therapeutics
MRKR
MRKR
65 hedge funds and large institutions have $44.5M invested in Marker Therapeutics in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less call options, than puts
Call options by funds: $160K | Put options by funds: $208K
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
49% less capital invested
Capital invested by funds: $87.6M → $44.5M (-$43.1M)
Holders
65
Holding in Top 10
1
Calls
$160K
Puts
$208K
Top Buyers
| 1 | +$482K | |
| 2 | +$427K | |
| 3 | +$343K | |
| 4 |
BlackRock
New York
|
+$265K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$150K |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$511K | |
| 3 | -$465K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$448K |
| 5 |
QCMA
Quad Capital Management Advisors
New York
|
-$298K |